Dr. Wayne Chadwick is Scientific Associate Director at Healx, an AI-driven drug discovery company dedicated to developing treatments for rare diseases. He holds a PhD in biochemistry from the University of Port Elizabeth, South Africa, and completed postdoctoral training in neuroscience at the US National Institute of Health. With over two decades of experience spanning academic research and the pharmaceutical industry Wayne has led multiple small molecule drug discovery programmes across neurodegenerative, neurodevelopmental and psychiatric disorders. At Healx, he has applied the company's AI platform to rare neurodevelopmental disorders, leading programmes in Fragile X syndrome and Angelman syndrome. He has authored over 30 peer reviewed publications and book chapters and has presented his research at international scientific conferences and patient community meetings.